At Stock Options Channel, our YieldBoost formula has looked up and down the NPSP options chain for the new May 2014 contracts and identified one put and one call contract of particular interest. The put contract at the …
Investors in NPS Pharmaceuticals Inc. (Symbol: NPSP) saw new options begin trading this week, for the September 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the …
NPS Pharmaceuticals (NPSP): NPSP stock is up 2.7% today ... Article printed from InvestorPlace Media, http://investorplace.com/2014/08/biggest-movers-in-healthcare-stocks-now-avnr-npsp-irwd-dgx-avnr-npsp
Health care
Why Wall Street loves NPS Pharmaceuticals Even more exciting than being a cheap stock, NPS has Wall Street analysts in its corner. Of the 13 analysts who have rated the stock, eight rate NPS the equivalent of a …
Wall Street
The author is long NPSP. The author wrote this article themselves, and it expresses their own opinions. The author is not receiving compensation for it (other than from Seeking Alpha). The author has no business …
Price
Rare-disease specialist NPS Pharmaceuticals (NPSP) is spiking on Friday after ... and showed little movement through the first 45 minutes of trading. However, the stock suddenly skyrocketed at 10:18 am ET, a time that …
Acquisitions and deals continue to be in focus with yet another pharma company announcing its intention to acquire a biotech company. Meanwhile, interest in the immuno-oncology area shows no signs of slowing down …
Strong
Retrophin Inc. (RTRX) traded at $14.76 + 1.88 (14.60 pct) on 3,252,808 total stock volume. The company is +110.86 pct year-to-date, and +116.59 pct during the past four quarters. NPS Pharmaceuticals Inc. (NPSP) …
NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) (the "Company") today announced that it has priced an underwritten public offering of 9,000,000 shares of its common stock at a price to the public of $5.50 per …
NPSP has a 1-year high of $45.75 and a 1-year low of $22.11. The stock’s 50-day moving average is $38.38 and it’s 200-day moving average is $30.74. On the ratings front, NPS Pharmaceuticals has been the subject of a …